Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs.
Increasing evidence suggests that thiazolidinediones (TZDs) could have a therapeutic potential for patients with cancers. Here, the evidence on the mechanisms by which TZDs could contribute to different steps of cancer biology in the digestive system is summarized. According to studies, TZDs induce anti-cancer actions through 3 main pathways: (1) cell growth arrest, (2) induction of apoptosis, and (3) inhibition of cell invasion. Cell growth arrest is induced by an increased level of p27(Kip1). p27(Kip1) accumulation results from the inhibition of the ubiquitin-proteasome system and/or inhibition of MEK-ERK signaling. TZDs induce apoptosis through increased levels of apoptotic molecules, such as p53 and PTEN and/or decreased level of anti-apoptotic molecules, such as Bcl-2 and survivin. Inhibition of MEK-ERK signaling-mediated up-regulation of E-cadherin and claudin-4, and/or decreased expression of matrix metalloproteinases (MMPs) such as MMP-2 and MMP-9, play a role in the TZD-induced inhibition of cancer cell invasion. Thus, TZDs are capable of inducing anti-tumor action in a variety of ways in gastrointestinal cancers.
Okumura
Toshikatsu
T
Department of General Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. okumurat@asahikawa-med.ac.jp
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009361:Neoplasm Invasiveness / Q000517:prevention & control; D045162:Thiazolidinediones / Q000494:pharmacology*
D000970:Antineoplastic Agents; D045162:Thiazolidinediones
Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9
19285010
Cancer Res. 2005 Feb 15;65(4):1561-9
15735046
Biochem Biophys Res Commun. 2005 Jun 24;332(1):89-94
15896303
Hepatology. 2005 Feb;41(2):237-46
15657914
Lancet Oncol. 2004 Jul;5(7):419-29
15231248
Hepatology. 2003 May;37(5):1086-96
12717389
J Clin Invest. 2000 Aug;106(4):467-72
10953021
Endocr Relat Cancer. 2007 Jun;14(2):305-15
17639046
J Clin Endocrinol Metab. 2005 Jul;90(7):3886-96
15886257
Cancer Res. 2005 Nov 1;65(21):9603-6
16266975
Nat Rev Cancer. 2009 Mar;9(3):153-66
19238148
J Biol Chem. 2001 Oct 12;276(41):37731-4
11459852
Cancer Res. 2003 Oct 1;63(19):6265-71
14559813
Toxicol Appl Pharmacol. 2009 Nov 1;240(3):348-54
19632256
Mol Pharmacol. 2005 Apr;67(4):1342-8
15653552
Science. 1995 Aug 4;269(5224):682-5
7624798
Cancer Metastasis Rev. 2006 Mar;25(1):9-34
16680569
Mol Cell Biol. 2001 May;21(9):3057-70
11287611
Gut. 2004 Mar;53(3):331-8
14960510
J Biol Chem. 2005 Feb 25;280(8):6742-51
15569667
Mol Cell. 2008 Apr 25;30(2):123-35
18439892
Br J Cancer. 2000 Nov;83(10):1394-400
11044367
Cancer Res. 2000 Feb 15;60(4):1129-38
10706135
Biochem Biophys Res Commun. 1997 Jun 9;235(1):113-6
9196046
Acta Pharmacol Sin. 2005 Jun;26(6):753-61
15916743
Diabet Med. 1999 Mar;16(3):179-92
10227562
Biochem Biophys Res Commun. 2000 Apr 13;270(2):400-5
10753637
J Biol Chem. 2000 Jan 21;275(3):1873-7
10636887
Am J Clin Oncol. 2004 Aug;27(4):425-8
15289739
J Biol Chem. 1999 May 14;274(20):13886-93
10318797
Cancer Chemother Pharmacol. 2005 Oct;56(4):400-8
15838654
J Invest Dermatol. 2004 Dec;123(6):1110-9
15610522
Jpn J Cancer Res. 2002 Jul;93(7):774-82
12149143
J Cell Physiol. 2006 Nov;209(2):428-38
16883598
Mol Cell Biol. 2006 Oct;26(20):7561-74
17015477
Nat Cell Biol. 1999 Aug;1(4):193-9
10559916
Cancer Sci. 2003 Apr;94(4):338-43
12824901
J Clin Endocrinol Metab. 2007 Feb;92(2):386-95
17148564
Apoptosis. 2006 Sep;11(9):1503-12
16820965
J Clin Oncol. 2007 Apr 20;25(12):1476-81
17442990
Curr Opin Cell Biol. 2005 Oct;17(5):548-58
16098727
Cancer Res. 2000 Oct 1;60(19):5558-64
11034103
Mol Cancer Ther. 2006 Feb;5(2):430-7
16505118
Gut. 2004 Nov;53(11):1688-97
15479693
Hepatology. 2001 May;33(5):1087-97
11343236
FEBS Lett. 1999 Jul 16;455(1-2):135-9
10428487
Clin Cancer Res. 2003 Jan;9(1):1-9
12538445
Cancer Lett. 2009 Apr 18;276(2):119-24
18790559
Thromb Haemost. 2004 Mar;91(3):438-49
14983218
Int J Cancer. 2004 Jan 1;108(1):41-6
14618613
Biochem Biophys Res Commun. 2001 Sep 7;286(5):916-22
11527386
Mol Cancer Res. 2006 Mar;4(3):159-67
16547153
World J Gastroenterol. 2008 Apr 14;14(14):2168-73
18407589